These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30236953)

  • 1. Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.
    Zinner SH; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2018 Dec; 52(6):854-860. PubMed ID: 30236953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.
    Zinner SH; Alieva KN; Golikova MV; Strukova EN; Portnoy YA; Firsov AA
    J Antimicrob Chemother; 2021 Jun; 76(7):1832-1839. PubMed ID: 33907810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetically-based prediction of the effects of antibiotic combinations on resistant Staphylococcus aureus mutants: in vitro model studies with linezolid and rifampicin.
    Firsov AA; Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH
    J Chemother; 2017 Aug; 29(4):220-226. PubMed ID: 27748167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model.
    Firsov AA; Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Romanov AV; Edelstein MV; Zinner SH
    J Antimicrob Chemother; 2017 Nov; 72(11):3100-3107. PubMed ID: 28981793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro resistance studies with bacteria that exhibit low mutation frequencies: prediction of "antimutant" linezolid concentrations using a mixed inoculum containing both susceptible and resistant Staphylococcus aureus.
    Firsov AA; Golikova MV; Strukova EN; Portnoy YA; Romanov AV; Edelstein MV; Zinner SH
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1014-9. PubMed ID: 25451050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolid.
    Alieva KN; Strukova EN; Golikova MV; Portnoy YA; Zinner SH; Firsov AA
    J Antibiot (Tokyo); 2018 May; 71(5):514-521. PubMed ID: 29348530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus.
    Golikova MV; Strukova EN; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
    J Chemother; 2017 Oct; 29(5):267-273. PubMed ID: 28192070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic Effects of Thiosemicarbazides with Clinical Drugs against
    Chudzik-Rząd B; Malm A; Trotsko N; Wujec M; Plech T; Paneth A
    Molecules; 2020 May; 25(10):. PubMed ID: 32422899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic model.
    Alieva KN; Golikova MV; Portnoy YA; Dovzhenko SA; Kobrin MB; Zinner SH; Firsov AA
    J Chemother; 2018; 30(6-8):364-370. PubMed ID: 30663551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus
    Kaul G; Akhir A; Shukla M; Shafi H; Akunuri R; Pawar G; Ghouse M; Srinivas N; Chopra S
    Microbiol Spectr; 2023 Aug; 11(4):e0503122. PubMed ID: 37428033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.
    Firsov AA; Vostrov SN; Lubenko IY; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2004 May; 23(5):451-6. PubMed ID: 15120722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
    LaPlante KL; Rybak MJ
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
    Strukova EN; Portnoy YA; Zinner SH; Firsov AA
    J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.
    Firsov AA; Smirnova MV; Strukova EN; Vostrov SN; Portnoy YA; Zinner SH
    Int J Antimicrob Agents; 2008 Dec; 32(6):488-93. PubMed ID: 18790614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
    Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of linezolid and daptomycin as an additive in Optisol-GS against methicillin-resistant Staphylococcus aureus.
    Li J; Feiz V; Vieira AC; Davis-Boozer D; Polage C
    Cornea; 2012 May; 31(5):551-8. PubMed ID: 22378113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against
    Golikova MV; Strukova EN; Portnoy YA; Zinner SH; Firsov AA
    Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.